

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.88760683 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.37437358 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.27197935 |
| 4 | vocalization behavior (GO:0071625) | 5.12122420 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.08756954 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 4.95850559 |
| 7 | locomotory exploration behavior (GO:0035641) | 4.93138368 |
| 8 | protein localization to synapse (GO:0035418) | 4.91785594 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.88698180 |
| 10 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.77766879 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.54113945 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.31435726 |
| 13 | exploration behavior (GO:0035640) | 4.27252939 |
| 14 | prepulse inhibition (GO:0060134) | 4.25234949 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.24733905 |
| 16 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.20264877 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.19210212 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.17032632 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.10024063 |
| 20 | neuron-neuron synaptic transmission (GO:0007270) | 4.09584863 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.02652967 |
| 22 | serotonin metabolic process (GO:0042428) | 4.02155467 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 4.00367984 |
| 24 | glutamate secretion (GO:0014047) | 3.99910612 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 3.99023572 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.96521322 |
| 27 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.93236951 |
| 28 | cell proliferation in forebrain (GO:0021846) | 3.90810957 |
| 29 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.89724829 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.89027259 |
| 31 | response to pheromone (GO:0019236) | 3.89024939 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.88908460 |
| 33 | sulfation (GO:0051923) | 3.84570193 |
| 34 | transmission of nerve impulse (GO:0019226) | 3.81136965 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.80632634 |
| 36 | striatum development (GO:0021756) | 3.80383910 |
| 37 | dendritic spine morphogenesis (GO:0060997) | 3.79165968 |
| 38 | response to histamine (GO:0034776) | 3.77552071 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75066059 |
| 40 | membrane hyperpolarization (GO:0060081) | 3.74635847 |
| 41 | primary amino compound metabolic process (GO:1901160) | 3.73550078 |
| 42 | regulation of germinal center formation (GO:0002634) | 3.72326882 |
| 43 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.70107337 |
| 44 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.69048649 |
| 45 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.68988297 |
| 46 | synaptic vesicle endocytosis (GO:0048488) | 3.65308582 |
| 47 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.65172740 |
| 48 | protein polyglutamylation (GO:0018095) | 3.63901108 |
| 49 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.62770076 |
| 50 | adaptation of signaling pathway (GO:0023058) | 3.62642688 |
| 51 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.59052986 |
| 52 | long-term synaptic potentiation (GO:0060291) | 3.56509336 |
| 53 | cellular response to ATP (GO:0071318) | 3.55675081 |
| 54 | negative regulation of response to food (GO:0032096) | 3.55408141 |
| 55 | negative regulation of appetite (GO:0032099) | 3.55408141 |
| 56 | synapse assembly (GO:0007416) | 3.55203414 |
| 57 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.54540826 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 3.53147362 |
| 59 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.49180240 |
| 60 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.48338837 |
| 61 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.44514829 |
| 62 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.43866812 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.43460535 |
| 64 | innervation (GO:0060384) | 3.42750477 |
| 65 | long-term memory (GO:0007616) | 3.41582404 |
| 66 | postsynaptic membrane organization (GO:0001941) | 3.41358173 |
| 67 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.40910003 |
| 68 | synaptic transmission, dopaminergic (GO:0001963) | 3.39256622 |
| 69 | behavioral response to cocaine (GO:0048148) | 3.38938603 |
| 70 | neuron recognition (GO:0008038) | 3.37922191 |
| 71 | positive regulation of synapse maturation (GO:0090129) | 3.37604881 |
| 72 | regulation of postsynaptic membrane potential (GO:0060078) | 3.37479154 |
| 73 | positive regulation of membrane potential (GO:0045838) | 3.35265209 |
| 74 | presynaptic membrane assembly (GO:0097105) | 3.34676098 |
| 75 | auditory behavior (GO:0031223) | 3.34396145 |
| 76 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.34138556 |
| 77 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.33773617 |
| 78 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.31411998 |
| 79 | sodium ion export (GO:0071436) | 3.30340744 |
| 80 | neuronal action potential propagation (GO:0019227) | 3.30123474 |
| 81 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.29264988 |
| 82 | response to auditory stimulus (GO:0010996) | 3.28803466 |
| 83 | neurotransmitter transport (GO:0006836) | 3.27354233 |
| 84 | behavioral defense response (GO:0002209) | 3.23793591 |
| 85 | behavioral fear response (GO:0001662) | 3.23793591 |
| 86 | dendrite morphogenesis (GO:0048813) | 3.23744923 |
| 87 | layer formation in cerebral cortex (GO:0021819) | 3.22570471 |
| 88 | presynaptic membrane organization (GO:0097090) | 3.20909699 |
| 89 | cerebellar granule cell differentiation (GO:0021707) | 3.17712528 |
| 90 | membrane depolarization during action potential (GO:0086010) | 3.17371697 |
| 91 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.15844133 |
| 92 | mating behavior (GO:0007617) | 3.13742280 |
| 93 | cell migration in hindbrain (GO:0021535) | 3.08429746 |
| 94 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.06704445 |
| 95 | adult walking behavior (GO:0007628) | 3.06025948 |
| 96 | potassium ion homeostasis (GO:0055075) | 3.05221647 |
| 97 | regulation of vesicle fusion (GO:0031338) | 3.04263762 |
| 98 | cellular anion homeostasis (GO:0030002) | 3.04208237 |
| 99 | fear response (GO:0042596) | 3.03373012 |
| 100 | axonal fasciculation (GO:0007413) | 3.03045511 |
| 101 | indole-containing compound metabolic process (GO:0042430) | 3.02808074 |
| 102 | regulation of activation of Janus kinase activity (GO:0010533) | 3.02756452 |
| 103 | synapse organization (GO:0050808) | 3.02389033 |
| 104 | regulation of memory T cell differentiation (GO:0043380) | 3.01274023 |
| 105 | startle response (GO:0001964) | 3.00943329 |
| 106 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.00819114 |
| 107 | regulation of synaptic plasticity (GO:0048167) | 3.00331249 |
| 108 | regulation of neurotransmitter secretion (GO:0046928) | 3.00228548 |
| 109 | membrane depolarization (GO:0051899) | 2.99835902 |
| 110 | learning (GO:0007612) | 2.99831275 |
| 111 | regulation of action potential (GO:0098900) | 2.98747143 |
| 112 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.97945574 |
| 113 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.97748467 |
| 114 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.97655507 |
| 115 | regulation of neurotransmitter levels (GO:0001505) | 2.97263656 |
| 116 | behavioral response to ethanol (GO:0048149) | 2.96764784 |
| 117 | regulation of synapse maturation (GO:0090128) | 2.96756339 |
| 118 | retinal rod cell development (GO:0046548) | 2.95565029 |
| 119 | regulation of membrane repolarization (GO:0060306) | 2.95435756 |
| 120 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.94682557 |
| 121 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.94682557 |
| 122 | somite development (GO:0061053) | 2.94371570 |
| 123 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.93610100 |
| 124 | detection of light stimulus involved in visual perception (GO:0050908) | 2.93610100 |
| 125 | dentate gyrus development (GO:0021542) | 2.92729996 |
| 126 | dopamine receptor signaling pathway (GO:0007212) | 2.92534197 |
| 127 | endoderm formation (GO:0001706) | 2.88512435 |
| 128 | nucleobase catabolic process (GO:0046113) | 2.88496112 |
| 129 | negative regulation of mast cell activation (GO:0033004) | 2.87606335 |
| 130 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.87344239 |
| 131 | otic vesicle formation (GO:0030916) | 2.86118736 |
| 132 | multicellular organism reproduction (GO:0032504) | 2.80732813 |
| 133 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.80608973 |
| 134 | positive regulation of action potential (GO:0045760) | 2.80125846 |
| 135 | positive regulation of defense response to virus by host (GO:0002230) | 2.79787751 |
| 136 | positive regulation of fatty acid oxidation (GO:0046321) | 2.79010241 |
| 137 | membrane repolarization during action potential (GO:0086011) | 2.77633580 |
| 138 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.73470671 |
| 139 | regulation of sequestering of triglyceride (GO:0010889) | 2.73346275 |
| 140 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.66913785 |
| 141 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.66817835 |
| 142 | parturition (GO:0007567) | 2.64615606 |
| 143 | positive regulation of fatty acid transport (GO:2000193) | 2.64402342 |
| 144 | RNA destabilization (GO:0050779) | 2.61837708 |
| 145 | regulation of acrosome reaction (GO:0060046) | 2.60440794 |
| 146 | regulation of mesoderm development (GO:2000380) | 2.58680913 |
| 147 | kynurenine metabolic process (GO:0070189) | 2.58577560 |
| 148 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.56550105 |
| 149 | regulation of glomerulus development (GO:0090192) | 2.56023860 |
| 150 | tryptophan catabolic process (GO:0006569) | 2.55364196 |
| 151 | indole-containing compound catabolic process (GO:0042436) | 2.55364196 |
| 152 | indolalkylamine catabolic process (GO:0046218) | 2.55364196 |
| 153 | regulation of skeletal muscle contraction (GO:0014819) | 2.55011022 |
| 154 | kidney morphogenesis (GO:0060993) | 2.54976364 |
| 155 | regulation of DNA endoreduplication (GO:0032875) | 2.54555410 |
| 156 | reflex (GO:0060004) | 2.53616424 |
| 157 | neuronal action potential (GO:0019228) | 2.53058738 |
| 158 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.52106908 |
| 159 | regulation of hippo signaling (GO:0035330) | 2.50786646 |
| 160 | rhodopsin mediated signaling pathway (GO:0016056) | 2.49780854 |
| 161 | regulation of female receptivity (GO:0045924) | 2.49142909 |
| 162 | synaptic transmission, cholinergic (GO:0007271) | 2.48053497 |
| 163 | multicellular organismal signaling (GO:0035637) | 2.45540278 |
| 164 | pharyngeal system development (GO:0060037) | 2.45325030 |
| 165 | response to inactivity (GO:0014854) | 2.43671367 |
| 166 | neuromuscular synaptic transmission (GO:0007274) | 2.43320451 |
| 167 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.42657597 |
| 168 | limb bud formation (GO:0060174) | 2.42597082 |
| 169 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.42108707 |
| 170 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.42108707 |
| 171 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.41264651 |
| 172 | cellular response to interleukin-15 (GO:0071350) | 2.41181875 |
| 173 | DNA methylation involved in gamete generation (GO:0043046) | 2.38830186 |
| 174 | prostate gland growth (GO:0060736) | 2.37845606 |
| 175 | axoneme assembly (GO:0035082) | 2.37554561 |
| 176 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.36590366 |
| 177 | action potential (GO:0001508) | 2.36351552 |
| 178 | DNA deamination (GO:0045006) | 2.35721214 |
| 179 | positive regulation of icosanoid secretion (GO:0032305) | 2.34555248 |
| 180 | mitotic cell cycle arrest (GO:0071850) | 2.33964817 |
| 181 | magnesium ion transport (GO:0015693) | 2.33819066 |
| 182 | positive regulation of cell fate commitment (GO:0010455) | 2.32863513 |
| 183 | L-fucose metabolic process (GO:0042354) | 2.31767750 |
| 184 | L-fucose catabolic process (GO:0042355) | 2.31767750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.41735719 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.76207006 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.26067452 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99215188 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93772475 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.85803569 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.54086535 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48525269 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46311951 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45855154 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45855154 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45410680 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45004072 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44303016 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42899298 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.42806575 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37439860 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37304179 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29509358 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28159040 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21716432 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18723327 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14554513 |
| 24 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14048442 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.13513607 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12931159 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01542870 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.98802085 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93175872 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.92273190 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90048695 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.88449838 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87373410 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.86378538 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83490165 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83267369 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75608936 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72689760 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70925849 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55559818 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.52857563 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52524096 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52275992 |
| 44 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.51370705 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49477380 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48384842 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47174081 |
| 48 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.46945799 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.46945799 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46548176 |
| 51 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45529613 |
| 52 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43340542 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41869034 |
| 54 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.39231384 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37890411 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37708543 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37492438 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33269518 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32898829 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31048577 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30950565 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30380539 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30317580 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30164668 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28672525 |
| 66 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27766599 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26746611 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26645332 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.25537270 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25488771 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24677647 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24656919 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23624073 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23061943 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22456398 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22421845 |
| 77 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.18884261 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17781565 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17163912 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16698255 |
| 81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.15907996 |
| 82 | EWS_26573619_Chip-Seq_HEK293_Human | 1.15342000 |
| 83 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14363969 |
| 84 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13569219 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13415111 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13145807 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12984456 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12415087 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12120693 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11782527 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11782527 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11677306 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09902152 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09883999 |
| 95 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09253009 |
| 96 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.08425198 |
| 97 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08376983 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08070575 |
| 99 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07851369 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07259495 |
| 101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04680592 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04358249 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03950098 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03249131 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03205046 |
| 106 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03154244 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02836822 |
| 108 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02516580 |
| 109 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02042056 |
| 110 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02028007 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00833707 |
| 112 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00372960 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99100370 |
| 114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98909087 |
| 115 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98263734 |
| 116 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97811686 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97806479 |
| 118 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97769090 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97714268 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97522630 |
| 121 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96742248 |
| 122 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96467942 |
| 123 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95161502 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95141352 |
| 125 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95080716 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93789480 |
| 127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91792670 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91772983 |
| 129 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91556053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.96143806 |
| 2 | MP0002822_catalepsy | 3.80655280 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.68934152 |
| 4 | MP0003880_abnormal_central_pattern | 3.64906352 |
| 5 | MP0009745_abnormal_behavioral_response | 3.39222195 |
| 6 | MP0009046_muscle_twitch | 3.13186046 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.06973943 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.05979908 |
| 9 | MP0003646_muscle_fatigue | 3.05374598 |
| 10 | MP0002064_seizures | 3.04119666 |
| 11 | MP0001486_abnormal_startle_reflex | 3.00868682 |
| 12 | MP0004270_analgesia | 2.99398940 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.73284087 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.59731836 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.58836848 |
| 16 | MP0001984_abnormal_olfaction | 2.55165669 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.53262645 |
| 18 | MP0002272_abnormal_nervous_system | 2.45077154 |
| 19 | MP0001502_abnormal_circadian_rhythm | 2.31974506 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.29978797 |
| 21 | MP0004130_abnormal_muscle_cell | 2.25514048 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.20885945 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.01034821 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.93688695 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.92893208 |
| 26 | MP0002184_abnormal_innervation | 1.92677015 |
| 27 | MP0001188_hyperpigmentation | 1.91755883 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.91180156 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.89180556 |
| 30 | MP0002160_abnormal_reproductive_system | 1.88874823 |
| 31 | MP0000778_abnormal_nervous_system | 1.88704267 |
| 32 | MP0002736_abnormal_nociception_after | 1.88391965 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 1.86046982 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.82012403 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.79683833 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.79051974 |
| 37 | MP0004885_abnormal_endolymph | 1.75005919 |
| 38 | MP0008569_lethality_at_weaning | 1.73415099 |
| 39 | MP0004924_abnormal_behavior | 1.72667204 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.72667204 |
| 41 | MP0001529_abnormal_vocalization | 1.71599804 |
| 42 | MP0003011_delayed_dark_adaptation | 1.68862608 |
| 43 | MP0004142_abnormal_muscle_tone | 1.67881926 |
| 44 | MP0001970_abnormal_pain_threshold | 1.66487941 |
| 45 | MP0003787_abnormal_imprinting | 1.64480670 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.64157337 |
| 47 | MP0005389_reproductive_system_phenotype | 1.61232247 |
| 48 | MP0002102_abnormal_ear_morphology | 1.58742090 |
| 49 | MP0005671_abnormal_response_to | 1.57888171 |
| 50 | MP0003195_calcinosis | 1.56683066 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.55227628 |
| 52 | MP0003879_abnormal_hair_cell | 1.49932520 |
| 53 | MP0000955_abnormal_spinal_cord | 1.48810474 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.48800055 |
| 55 | MP0002090_abnormal_vision | 1.48553048 |
| 56 | MP0002163_abnormal_gland_morphology | 1.43937013 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.43192263 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.43187532 |
| 59 | MP0005253_abnormal_eye_physiology | 1.42405350 |
| 60 | MP0005499_abnormal_olfactory_system | 1.39781284 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.39781284 |
| 62 | MP0000049_abnormal_middle_ear | 1.38204091 |
| 63 | MP0006292_abnormal_olfactory_placode | 1.37865037 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.36964479 |
| 65 | MP0000631_abnormal_neuroendocrine_gland | 1.36921405 |
| 66 | MP0003329_amyloid_beta_deposits | 1.31979395 |
| 67 | MP0002229_neurodegeneration | 1.24921449 |
| 68 | MP0002752_abnormal_somatic_nervous | 1.19179148 |
| 69 | MP0004742_abnormal_vestibular_system | 1.18174334 |
| 70 | MP0004858_abnormal_nervous_system | 1.16397589 |
| 71 | MP0002152_abnormal_brain_morphology | 1.16386767 |
| 72 | MP0003878_abnormal_ear_physiology | 1.15258567 |
| 73 | MP0005377_hearing/vestibular/ear_phenot | 1.15258567 |
| 74 | MP0001919_abnormal_reproductive_system | 1.12527006 |
| 75 | MP0009250_abnormal_appendicular_skeleto | 1.12512883 |
| 76 | MP0003633_abnormal_nervous_system | 1.12375490 |
| 77 | MP0005409_darkened_coat_color | 1.09394902 |
| 78 | MP0006276_abnormal_autonomic_nervous | 1.07765871 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 1.07330512 |
| 80 | MP0001905_abnormal_dopamine_level | 1.06924339 |
| 81 | MP0003137_abnormal_impulse_conducting | 1.06420654 |
| 82 | MP0004233_abnormal_muscle_weight | 1.02569499 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.99263499 |
| 84 | MP0005195_abnormal_posterior_eye | 0.98705026 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.98366781 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.98019916 |
| 87 | MP0002928_abnormal_bile_duct | 0.97872306 |
| 88 | MP0003631_nervous_system_phenotype | 0.97750470 |
| 89 | MP0004215_abnormal_myocardial_fiber | 0.96800320 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.95461356 |
| 91 | MP0003634_abnormal_glial_cell | 0.94674116 |
| 92 | MP0003724_increased_susceptibility_to | 0.93568786 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.93278390 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.93215015 |
| 95 | MP0001177_atelectasis | 0.93197688 |
| 96 | MP0004134_abnormal_chest_morphology | 0.93101910 |
| 97 | MP0003638_abnormal_response/metabolism_ | 0.92674135 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.92171446 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.90838384 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.89310518 |
| 101 | MP0008789_abnormal_olfactory_epithelium | 0.88789766 |
| 102 | MP0008872_abnormal_physiological_respon | 0.87337174 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 0.87218950 |
| 104 | MP0004145_abnormal_muscle_electrophysio | 0.86297536 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.85670358 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.85451444 |
| 107 | MP0009053_abnormal_anal_canal | 0.83188287 |
| 108 | MP0003122_maternal_imprinting | 0.82060716 |
| 109 | MP0004085_abnormal_heartbeat | 0.81761719 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.81698688 |
| 111 | MP0004133_heterotaxia | 0.81612225 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.80859896 |
| 113 | MP0003938_abnormal_ear_development | 0.79824829 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79520251 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.79328244 |
| 116 | MP0003690_abnormal_glial_cell | 0.77508390 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.77182437 |
| 118 | MP0005360_urolithiasis | 0.77175783 |
| 119 | MP0000026_abnormal_inner_ear | 0.76492684 |
| 120 | MP0000920_abnormal_myelination | 0.75921777 |
| 121 | MP0003252_abnormal_bile_duct | 0.74518849 |
| 122 | MP0003632_abnormal_nervous_system | 0.73939219 |
| 123 | MP0000678_abnormal_parathyroid_gland | 0.73518382 |
| 124 | MP0002938_white_spotting | 0.72687219 |
| 125 | MP0002932_abnormal_joint_morphology | 0.72588954 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.68190735 |
| 127 | MP0000751_myopathy | 0.66674370 |
| 128 | MP0008874_decreased_physiological_sensi | 0.63487927 |
| 129 | MP0004043_abnormal_pH_regulation | 0.61754040 |
| 130 | MP0003861_abnormal_nervous_system | 0.60848636 |
| 131 | MP0005595_abnormal_vascular_smooth | 0.60618103 |
| 132 | MP0002082_postnatal_lethality | 0.59551921 |
| 133 | MP0010770_preweaning_lethality | 0.59551921 |
| 134 | MP0010769_abnormal_survival | 0.57174037 |
| 135 | MP0001943_abnormal_respiration | 0.54556714 |
| 136 | MP0010768_mortality/aging | 0.54441896 |
| 137 | MP0001986_abnormal_taste_sensitivity | 0.52467239 |
| 138 | MP0005171_absent_coat_pigmentation | 0.51415444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.73030335 |
| 2 | Myokymia (HP:0002411) | 5.59518637 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.46480318 |
| 4 | Febrile seizures (HP:0002373) | 5.05088395 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.98508487 |
| 6 | Focal seizures (HP:0007359) | 4.88910865 |
| 7 | Visual hallucinations (HP:0002367) | 4.21763112 |
| 8 | Abnormality of macular pigmentation (HP:0008002) | 4.12968416 |
| 9 | Absence seizures (HP:0002121) | 4.12019605 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.93935024 |
| 11 | Central scotoma (HP:0000603) | 3.92324707 |
| 12 | Atonic seizures (HP:0010819) | 3.90632768 |
| 13 | Congenital sensorineural hearing impairment (HP:0008527) | 3.81035211 |
| 14 | Dialeptic seizures (HP:0011146) | 3.71759870 |
| 15 | Septo-optic dysplasia (HP:0100842) | 3.70346514 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 3.52055874 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.41087957 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.37203109 |
| 19 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.29859857 |
| 20 | Severe visual impairment (HP:0001141) | 3.29679756 |
| 21 | Action tremor (HP:0002345) | 3.25544549 |
| 22 | Broad-based gait (HP:0002136) | 3.24494148 |
| 23 | Attenuation of retinal blood vessels (HP:0007843) | 3.13403967 |
| 24 | Drooling (HP:0002307) | 3.11469791 |
| 25 | Excessive salivation (HP:0003781) | 3.11469791 |
| 26 | IgG deficiency (HP:0004315) | 3.09709459 |
| 27 | Agitation (HP:0000713) | 3.00491908 |
| 28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.98840364 |
| 29 | Mutism (HP:0002300) | 2.97428277 |
| 30 | Hemiparesis (HP:0001269) | 2.96815190 |
| 31 | Pancreatic cysts (HP:0001737) | 2.95765468 |
| 32 | Decreased circulating renin level (HP:0003351) | 2.95177431 |
| 33 | Hyperventilation (HP:0002883) | 2.94025299 |
| 34 | Mesomelia (HP:0003027) | 2.93332010 |
| 35 | Nephronophthisis (HP:0000090) | 2.91635499 |
| 36 | Scanning speech (HP:0002168) | 2.88288104 |
| 37 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.88073061 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.87390128 |
| 39 | Supranuclear gaze palsy (HP:0000605) | 2.85128505 |
| 40 | Short tibia (HP:0005736) | 2.84049817 |
| 41 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.82073827 |
| 42 | Asplenia (HP:0001746) | 2.82071818 |
| 43 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.77401727 |
| 44 | Depression (HP:0000716) | 2.76903654 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.76737296 |
| 46 | Ankle clonus (HP:0011448) | 2.75834711 |
| 47 | Pendular nystagmus (HP:0012043) | 2.71527651 |
| 48 | Dysmetria (HP:0001310) | 2.69948648 |
| 49 | Poor eye contact (HP:0000817) | 2.69920326 |
| 50 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.68798537 |
| 51 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.65611528 |
| 52 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.65059172 |
| 53 | Methylmalonic acidemia (HP:0002912) | 2.63554836 |
| 54 | True hermaphroditism (HP:0010459) | 2.62575143 |
| 55 | Abnormality of the renal collecting system (HP:0004742) | 2.59893971 |
| 56 | Decreased central vision (HP:0007663) | 2.59873983 |
| 57 | Impaired social interactions (HP:0000735) | 2.56716121 |
| 58 | Abnormal social behavior (HP:0012433) | 2.56716121 |
| 59 | Abnormality of the renal cortex (HP:0011035) | 2.56484847 |
| 60 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.55733389 |
| 61 | Scotoma (HP:0000575) | 2.54598762 |
| 62 | Abnormality of the renal medulla (HP:0100957) | 2.53104348 |
| 63 | Hemiplegia (HP:0002301) | 2.52156329 |
| 64 | Anxiety (HP:0000739) | 2.50621132 |
| 65 | Clumsiness (HP:0002312) | 2.50214665 |
| 66 | Adactyly (HP:0009776) | 2.50135021 |
| 67 | Epileptiform EEG discharges (HP:0011182) | 2.47649255 |
| 68 | Short femoral neck (HP:0100864) | 2.46808922 |
| 69 | Postural instability (HP:0002172) | 2.44971478 |
| 70 | Truncal ataxia (HP:0002078) | 2.44155610 |
| 71 | EEG with generalized epileptiform discharges (HP:0011198) | 2.43460711 |
| 72 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.43041645 |
| 73 | Radial bowing (HP:0002986) | 2.41675642 |
| 74 | Increased corneal curvature (HP:0100692) | 2.40935682 |
| 75 | Keratoconus (HP:0000563) | 2.40935682 |
| 76 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.38779580 |
| 77 | Type II lissencephaly (HP:0007260) | 2.38701313 |
| 78 | Spastic gait (HP:0002064) | 2.38435360 |
| 79 | Neurofibrillary tangles (HP:0002185) | 2.38249731 |
| 80 | Abnormal eating behavior (HP:0100738) | 2.35376962 |
| 81 | Absent septum pellucidum (HP:0001331) | 2.35030490 |
| 82 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.34774470 |
| 83 | Short 4th metacarpal (HP:0010044) | 2.34774470 |
| 84 | Optic nerve hypoplasia (HP:0000609) | 2.34648243 |
| 85 | Abnormality of binocular vision (HP:0011514) | 2.34620116 |
| 86 | Diplopia (HP:0000651) | 2.34620116 |
| 87 | Genetic anticipation (HP:0003743) | 2.31361423 |
| 88 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.28184923 |
| 89 | Metabolic alkalosis (HP:0200114) | 2.28099855 |
| 90 | Stomach cancer (HP:0012126) | 2.26881978 |
| 91 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.25447896 |
| 92 | Hypsarrhythmia (HP:0002521) | 2.24273493 |
| 93 | Methylmalonic aciduria (HP:0012120) | 2.21727013 |
| 94 | Short 1st metacarpal (HP:0010034) | 2.21723159 |
| 95 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.21723159 |
| 96 | Thyroiditis (HP:0100646) | 2.21529940 |
| 97 | Torticollis (HP:0000473) | 2.20869926 |
| 98 | Intention tremor (HP:0002080) | 2.20108827 |
| 99 | Renal cortical cysts (HP:0000803) | 2.17571459 |
| 100 | Gait imbalance (HP:0002141) | 2.17419360 |
| 101 | Molar tooth sign on MRI (HP:0002419) | 2.17392496 |
| 102 | Abnormality of midbrain morphology (HP:0002418) | 2.17392496 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.15186386 |
| 104 | Abnormality of the corticospinal tract (HP:0002492) | 2.13776516 |
| 105 | Abnormality of salivation (HP:0100755) | 2.13541888 |
| 106 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.11247473 |
| 107 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.11140269 |
| 108 | Absent/shortened dynein arms (HP:0200106) | 2.11140269 |
| 109 | Hypoplasia of the ulna (HP:0003022) | 2.10847398 |
| 110 | Impaired smooth pursuit (HP:0007772) | 2.10814606 |
| 111 | Status epilepticus (HP:0002133) | 2.09942615 |
| 112 | Progressive inability to walk (HP:0002505) | 2.09531599 |
| 113 | Polyphagia (HP:0002591) | 2.08779999 |
| 114 | Prolonged QT interval (HP:0001657) | 2.07731062 |
| 115 | Small hand (HP:0200055) | 2.07507138 |
| 116 | Stereotypic behavior (HP:0000733) | 2.07184120 |
| 117 | Fibular aplasia (HP:0002990) | 2.06573800 |
| 118 | Porencephaly (HP:0002132) | 2.05953365 |
| 119 | Oligodontia (HP:0000677) | 2.05050444 |
| 120 | Amblyopia (HP:0000646) | 2.04946014 |
| 121 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.04874214 |
| 122 | Syncope (HP:0001279) | 2.04494536 |
| 123 | Absent speech (HP:0001344) | 2.03928987 |
| 124 | Bradykinesia (HP:0002067) | 2.03332436 |
| 125 | Urinary urgency (HP:0000012) | 2.02458287 |
| 126 | Blue irides (HP:0000635) | 2.02004533 |
| 127 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.01867220 |
| 128 | Cerebral inclusion bodies (HP:0100314) | 2.01336008 |
| 129 | Limb dystonia (HP:0002451) | 2.00675562 |
| 130 | Thyroid-stimulating hormone excess (HP:0002925) | 2.00638557 |
| 131 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.98618024 |
| 132 | Megalencephaly (HP:0001355) | 1.98094109 |
| 133 | Medial flaring of the eyebrow (HP:0010747) | 1.97565180 |
| 134 | Abnormality of the lower motor neuron (HP:0002366) | 1.97038406 |
| 135 | Abnormality of the 4th metacarpal (HP:0010012) | 1.95467596 |
| 136 | Abnormality of the septum pellucidum (HP:0007375) | 1.94679350 |
| 137 | Abnormality of the 1st metacarpal (HP:0010009) | 1.94469450 |
| 138 | Abnormality of eosinophils (HP:0001879) | 1.91239098 |
| 139 | Pachygyria (HP:0001302) | 1.91084266 |
| 140 | Volvulus (HP:0002580) | 1.88824635 |
| 141 | Severe combined immunodeficiency (HP:0004430) | 1.86704772 |
| 142 | Tented upper lip vermilion (HP:0010804) | 1.86683963 |
| 143 | Focal dystonia (HP:0004373) | 1.86552769 |
| 144 | Polydipsia (HP:0001959) | 1.85725142 |
| 145 | Abnormal drinking behavior (HP:0030082) | 1.85725142 |
| 146 | Synostosis of carpal bones (HP:0005048) | 1.85648058 |
| 147 | Hypoplasia of the uterus (HP:0000013) | 1.83260890 |
| 148 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.83228078 |
| 149 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.83132709 |
| 150 | Growth hormone deficiency (HP:0000824) | 1.82894803 |
| 151 | Conical tooth (HP:0000698) | 1.82590884 |
| 152 | Protruding tongue (HP:0010808) | 1.82385320 |
| 153 | Absent phalangeal crease (HP:0006109) | 1.81019190 |
| 154 | Duplicated collecting system (HP:0000081) | 1.80681150 |
| 155 | Fibular hypoplasia (HP:0003038) | 1.80672242 |
| 156 | Specific learning disability (HP:0001328) | 1.80473368 |
| 157 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.79976924 |
| 158 | Neuronal loss in central nervous system (HP:0002529) | 1.79786648 |
| 159 | Abnormal ciliary motility (HP:0012262) | 1.78662014 |
| 160 | Narrow nasal bridge (HP:0000446) | 1.78477150 |
| 161 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.77527144 |
| 162 | Generalized myoclonic seizures (HP:0002123) | 1.77270432 |
| 163 | Abnormality of the 2nd finger (HP:0004100) | 1.77075210 |
| 164 | Abnormality of DNA repair (HP:0003254) | 1.77058267 |
| 165 | Inability to walk (HP:0002540) | 1.75683669 |
| 166 | Lower limb muscle weakness (HP:0007340) | 1.75593103 |
| 167 | Fetal akinesia sequence (HP:0001989) | 1.73778802 |
| 168 | Craniofacial dystonia (HP:0012179) | 1.71905211 |
| 169 | Abnormal EKG (HP:0003115) | 1.71688124 |
| 170 | Dysmetric saccades (HP:0000641) | 1.71460419 |
| 171 | Incomplete penetrance (HP:0003829) | 1.71288648 |
| 172 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.70757663 |
| 173 | Hypoplasia of the fovea (HP:0007750) | 1.70757663 |
| 174 | Congenital primary aphakia (HP:0007707) | 1.70664353 |
| 175 | Thickened helices (HP:0000391) | 1.68359506 |
| 176 | Cone-rod dystrophy (HP:0000548) | 1.67707412 |
| 177 | Genital tract atresia (HP:0001827) | 1.66664021 |
| 178 | Choroideremia (HP:0001139) | 1.66442765 |
| 179 | Autism (HP:0000717) | 1.66056657 |
| 180 | Neoplasm of the heart (HP:0100544) | 1.65958719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.19930649 |
| 2 | MARK1 | 4.08476624 |
| 3 | FRK | 3.78716650 |
| 4 | EPHA4 | 3.72012014 |
| 5 | MAP3K9 | 3.34223277 |
| 6 | ADRBK2 | 3.05850745 |
| 7 | MAP3K4 | 2.93861962 |
| 8 | CASK | 2.75031654 |
| 9 | TNIK | 2.74852459 |
| 10 | NTRK2 | 2.48331739 |
| 11 | MINK1 | 2.45677043 |
| 12 | PAK6 | 2.43780724 |
| 13 | MAP2K2 | 2.42904688 |
| 14 | TLK1 | 2.31792587 |
| 15 | MAP4K2 | 2.30094333 |
| 16 | MAP2K7 | 2.23780220 |
| 17 | GRK6 | 2.22702223 |
| 18 | BCKDK | 2.18483831 |
| 19 | GRK1 | 2.13235299 |
| 20 | WNK4 | 2.06349269 |
| 21 | PRPF4B | 1.89800812 |
| 22 | OBSCN | 1.74952531 |
| 23 | PHKG2 | 1.67899328 |
| 24 | PHKG1 | 1.67899328 |
| 25 | NUAK1 | 1.62907430 |
| 26 | DAPK2 | 1.62357979 |
| 27 | ZAK | 1.58964519 |
| 28 | GRK7 | 1.53895807 |
| 29 | PRKD2 | 1.51673626 |
| 30 | KSR1 | 1.51549418 |
| 31 | MAPK13 | 1.47239536 |
| 32 | CDK5 | 1.42316199 |
| 33 | MAP3K13 | 1.39904362 |
| 34 | SGK494 | 1.33513340 |
| 35 | SGK223 | 1.33513340 |
| 36 | MAP2K4 | 1.33377077 |
| 37 | MAP3K14 | 1.32292174 |
| 38 | STK39 | 1.28834669 |
| 39 | SIK2 | 1.25339325 |
| 40 | PNCK | 1.22996052 |
| 41 | FES | 1.21864390 |
| 42 | KIT | 1.21243903 |
| 43 | CAMKK1 | 1.18686655 |
| 44 | SGK2 | 1.18379991 |
| 45 | NTRK1 | 1.12040137 |
| 46 | TAOK1 | 1.10758725 |
| 47 | DYRK1A | 1.09195520 |
| 48 | KSR2 | 1.05905615 |
| 49 | PRKCG | 1.05846085 |
| 50 | STK16 | 1.05488996 |
| 51 | CAMK2A | 1.04523184 |
| 52 | MUSK | 1.04092888 |
| 53 | ARAF | 1.03430021 |
| 54 | MAP3K12 | 1.03400777 |
| 55 | RIPK4 | 1.00376299 |
| 56 | STK38 | 0.98726826 |
| 57 | GRK5 | 0.98146972 |
| 58 | ADRBK1 | 0.96009588 |
| 59 | CAMKK2 | 0.95938368 |
| 60 | WNK3 | 0.95007480 |
| 61 | NME1 | 0.94976314 |
| 62 | SGK3 | 0.94047254 |
| 63 | IKBKB | 0.91710637 |
| 64 | PRKCQ | 0.90297394 |
| 65 | PKN1 | 0.90249508 |
| 66 | PRKCE | 0.88829539 |
| 67 | UHMK1 | 0.88817272 |
| 68 | NEK6 | 0.88508296 |
| 69 | PIK3CA | 0.87912924 |
| 70 | TAOK2 | 0.87327440 |
| 71 | PRKD3 | 0.86787839 |
| 72 | LMTK2 | 0.86085482 |
| 73 | MARK2 | 0.83851333 |
| 74 | SGK1 | 0.83500692 |
| 75 | PLK2 | 0.82600743 |
| 76 | CAMK2B | 0.80823927 |
| 77 | MAPK7 | 0.80625034 |
| 78 | RPS6KA2 | 0.79233917 |
| 79 | PRKCZ | 0.77514868 |
| 80 | STK11 | 0.77321104 |
| 81 | DAPK1 | 0.76961842 |
| 82 | TIE1 | 0.73511888 |
| 83 | AKT3 | 0.73455692 |
| 84 | PRKCH | 0.72847967 |
| 85 | MAPK4 | 0.72242648 |
| 86 | CAMK2D | 0.71003380 |
| 87 | RPS6KA6 | 0.70697673 |
| 88 | INSRR | 0.70628247 |
| 89 | PAK3 | 0.70431991 |
| 90 | MAP2K1 | 0.69418040 |
| 91 | WNK1 | 0.69396860 |
| 92 | CAMK1 | 0.69312510 |
| 93 | EPHB2 | 0.68743143 |
| 94 | ERBB3 | 0.68425946 |
| 95 | CDK18 | 0.68404025 |
| 96 | ERBB2 | 0.67172765 |
| 97 | CDK15 | 0.66272630 |
| 98 | CDK14 | 0.66150158 |
| 99 | SYK | 0.65477660 |
| 100 | MAP3K2 | 0.65364949 |
| 101 | TNK2 | 0.65108360 |
| 102 | SIK3 | 0.64062881 |
| 103 | CSNK1G2 | 0.63513329 |
| 104 | CAMK2G | 0.63162231 |
| 105 | MAP4K1 | 0.62959612 |
| 106 | BMPR2 | 0.61505267 |
| 107 | BMPR1B | 0.60798044 |
| 108 | PINK1 | 0.59863588 |
| 109 | RPS6KA3 | 0.58988170 |
| 110 | MAP3K7 | 0.58207739 |
| 111 | MAPK10 | 0.57637624 |
| 112 | CSNK1G1 | 0.57310926 |
| 113 | CDC42BPA | 0.56845537 |
| 114 | OXSR1 | 0.56591400 |
| 115 | MAPK15 | 0.55362145 |
| 116 | CDK11A | 0.55116301 |
| 117 | LATS2 | 0.54289381 |
| 118 | CDK3 | 0.53288200 |
| 119 | FGFR2 | 0.52114351 |
| 120 | PRKCB | 0.51071546 |
| 121 | CSNK1G3 | 0.50485500 |
| 122 | EPHA3 | 0.50026356 |
| 123 | TAOK3 | 0.49970810 |
| 124 | RAF1 | 0.48892151 |
| 125 | FYN | 0.48583681 |
| 126 | ITK | 0.48473478 |
| 127 | CLK1 | 0.48172337 |
| 128 | TEC | 0.47601385 |
| 129 | CAMK1G | 0.47529728 |
| 130 | IGF1R | 0.46699818 |
| 131 | CSNK1D | 0.46609871 |
| 132 | RET | 0.46598695 |
| 133 | RPS6KL1 | 0.46574852 |
| 134 | RPS6KC1 | 0.46574852 |
| 135 | PRKG1 | 0.46157682 |
| 136 | BRD4 | 0.45936716 |
| 137 | PRKCI | 0.45764043 |
| 138 | CAMK4 | 0.44875815 |
| 139 | MAPK12 | 0.44220723 |
| 140 | PRKACA | 0.44044960 |
| 141 | TXK | 0.43961146 |
| 142 | FER | 0.43584079 |
| 143 | GSK3B | 0.42278295 |
| 144 | CSNK1A1 | 0.42142303 |
| 145 | CDK8 | 0.41830048 |
| 146 | TYRO3 | 0.41675534 |
| 147 | PRKCA | 0.41608755 |
| 148 | DYRK2 | 0.41533576 |
| 149 | CCNB1 | 0.40578223 |
| 150 | ACVR1B | 0.39971687 |
| 151 | MAP2K6 | 0.39694109 |
| 152 | IKBKE | 0.39505543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.17878644 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 3.18062109 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.00518963 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 2.92155405 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.90591871 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68843658 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.52965557 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.48944179 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.43579574 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.12415681 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.04359610 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03949165 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96410476 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.96118461 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.92010009 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.88618916 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.84056066 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.74673230 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74401038 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.73893213 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72753950 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.70156052 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69383518 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.69346624 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61677905 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.60994309 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.59683581 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59588036 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.52193057 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51504728 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.50875934 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.50009707 |
| 33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49114592 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44226416 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.43496230 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42205693 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41570367 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41249882 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30635140 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.27981598 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25998098 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24396844 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24211773 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24127830 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21606375 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21603960 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20632396 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.15809728 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13685594 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12449938 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 1.11919600 |
| 52 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.11238569 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10562502 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07124389 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03108227 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99390136 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99057201 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96538697 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96150911 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93926790 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93665457 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92052265 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91779126 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90914882 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90829191 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89366089 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88031236 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87574407 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84586997 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82057865 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81517515 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81467907 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81214975 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80743081 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.79930745 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78924685 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78820109 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76268478 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75099614 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.75054561 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74678543 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74382451 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72223516 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71975146 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.70544325 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69905997 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69627395 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67107481 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.65774323 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65726251 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65517067 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.64224564 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63983697 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63356461 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62438262 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60421448 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60180235 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58795583 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58595201 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56781478 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55996933 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.53407794 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53241720 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53197997 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52749858 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52420337 |
| 107 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52373184 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51362626 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49725814 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49656272 |
| 111 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47213900 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47124893 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46559785 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46364199 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45788490 |
| 116 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45429991 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44969276 |
| 118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44844290 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.43108756 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43085205 |
| 121 | Allograft rejection_Homo sapiens_hsa05330 | 0.42493996 |
| 122 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41629603 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40865713 |
| 124 | Bile secretion_Homo sapiens_hsa04976 | 0.40388292 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38573843 |
| 126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38094589 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.38020208 |
| 128 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37501195 |
| 129 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37219561 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36031228 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35880936 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34986114 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34199359 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33407200 |
| 135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31205332 |
| 136 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30736051 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30080597 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29802931 |
| 139 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29589602 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.28752897 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.24420464 |
| 142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23941955 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21728741 |
| 144 | Colorectal cancer_Homo sapiens_hsa05210 | 0.21447412 |
| 145 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21214793 |
| 146 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20864916 |

